AI Summary & Key Takeaways
AI InsightP wave duration was notably higher when compared before and after smokingcessation with bupropion (99.0 ± 15.7 ms vs 96.2 ± 11.9ms; p120 mswas significantly higher in smoking patients. (p=0.014) The frequency of the patients with P wave duration
📌 3 Key Takeaways
Abstract
Aim: In the current study, the impact of smoking cessation with and without bupropion usage on p wave duration and p waveamplitude in lead I has been analyzed. Bupropion, which is an atypical antidepressant with effects on both dopaminergic andnoradrenergic systems, is approved in the medical treatment of smoking cessation. Several cardiac side effects have been presentedwhen bupropion is prescribed in smoking cessation.Material and Methods: Our study has a prospective design which has planned to evaluate p wave amplitude in lead I and p waveduration changes of bupropion by comparing smoking patients (n=78) before and after bupropion usage. The patients prescribedbupropion were also compared to ex-smoker group (n=50) who quit smoking without bupropion usage in regard to p wave indicesin lead I. Differences in the median values between groups were analyzed using Mann-Whitney U test. Categorical variables wereanalyzed by chi-square test or Fisher’s exact test. For repeated measurements, paired sample t-test and Wilcoxon signed rank testswere used to evaluate the significance of the difference in parameters with normal and skewed distribution.Results: The study included both seventy-eight (79.5% male) patients under bupropion treatment and fifty (88.2% male) patientsstopped smoking without pharmacotherapy. P wave duration was notably higher when compared before and after smokingcessation with bupropion (99.0 ± 15.7 ms vs 96.2 ± 11.9ms; p120 mswas significantly higher in smoking patients. (p=0.014) The frequency of the patients with P wave duration